Diagnostical value of methods for cognitive impairments assessing in patients with liver cirrhosis


DOI: https://dx.doi.org/10.18565/therapy.2024.5.31-38

Galieva A.M., Mukhametova D.D., Belousova E.N., Khazieva G.R., Valitova A.D., Levanova P.I., Odintsova A.Kh., Abdulganieva D.I.

1) Kazan State Medical University of the Ministry of Healthcare of Russia; 2) Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan, Kazan
Abstract. Hepatic encephalopathy (HE) is the most common and serious complication of liver cirrhosis (LC). Its clinical picture can be varied – from minimal cognitive impairment to profound impairment of consciousness. There is no specific method for HE diagnosing.
The aim: to estimate the diagnostic value of tests used to evaluate HE in LC patients.
Material and methods. 86 LC patients hospitalized in gastroenterology department of Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan, Kazan were involved in the study. The average age of patients was 52 [43; 62] years, rate of females was 65%. For determination the stage of HE West – Haven criteria were used. The average MELD score was 14 [9; 20]. Number connecting test (NCT), MoCA scale, MMSE scale and blood ammonium level assessment were used in 84, 26, 28 and 45 patients, respectively.
Results. According to West – Haven criteria, 78 (90%) participants had HE: minimal HE – 22 (26%), stage 1 HE – 42 (50%), stage 2 HE – 14 (14%) persons. In 73 (87%) patients, the time required to perform NCT exceeded the norm. The average NCT value was 68 [49; 110.5] sec. Sensitivity of NCT for HE detecting was 93.4%, specificity – 75%, positive predictive value (PPV) – 97.3%. In 14 patients (54%), MoCA test scores were below normal, the average score was 25 [20; 28]. MoCA had a sensitivity for detecting HE of 63.6%, specificity of 100%, and PPV of 100%. In 20 patients (71%), the result on the MMSE test was below normal, the average score was 26.5 [24; 29]. The sensitivity of MMSE was 79.2%, specificity – 75%, PPV – 95%. 41 patients (91%) had elevated levels of ammonium in the blood, and 4 had normal levels. The average value of this indicator was 97 [66; 177] µmol/l. Sensitivity of blood ammonium determination for identifying HE was 90.24%, PPV – 90.24%.
Conclusion. NCT had the highest sensitivity for HE detecting, but its specificity was comparable to MMSE. MoCA had the highest specificity but low sensitivity. High sensitivity for HE detecting was also fixed for ammonium level determination.

Literature


1. Ивашкин В.Т., Маевская М.В., Жаркова М.С. с соавт. Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по диагностике и лечению фиброза и цирроза печени и их осложнений. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021; 31(6): 56–102. (Ivashkin V.T., Maevskaya M.V., Zharkova M.S. et al. Clinical recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on diagnosis and treatment of liver fibrosis, cirrhosis and their complications. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021; 31(6): 56–102 (In Russ.)).


https://doi.org/10.22416/1382-4376-2021-31-6-56-102. EDN: GMKWTQ.


2. Vidal-Cevallos P., Chávez-Tapia N.C., Uribe M. Current approaches to hepatic encephalopathy. Ann Hepatol. 2022; 27(6): 100757.


https://doi.org/10.1016/j.aohep.2022.100757. PMID: 36115576.


3. Hadjihambi A., Arias N., Sheikh M., Jalan R. Hepatic encephalopathy: A critical current review. Hepatol Int. 2018; 12(Suppl 1): 135–47.


https://doi.org/10.1007/s12072-017-9812-3. PMID: 28770516. PMCID: PMC5830466.


4. American Association for the Study of Liver Diseases; European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014; 61(3): 642–59.


http://dx.doi.org/10.1016/j.jhep.2014.05.042. PMID: 25015420.


5. Акберова Д.Р. Степень усталости и когнитивных расстройств у пациентов с аутоиммунными заболеваниями печени. В кн.: Сборник тезисов 90-й Всероссийской научно-практической конференции студентов и молодых ученых. Казань: Казанский государственный медицинский университет. 2016; 82 с. (Akberova D.R. The degree of fatigue and cognitive impairment in patients with autoimmune liver diseases. In the book: Collection of abstracts of the 90th All-Russian Scientific and Practical Conference of Students and Young Scientists. Kazan: Kazan State Medical University. 2016; 82 pp. (In Russ.)). EDN: RYWFVO.


6. Максимова Е.В., Кляритская И.Л. Печеночная энцефалопатия, диагностика, дифференциальная диагностика и терапия при помощи орнитина. Consilium Medicum. 2018; 20(12): 110–116. (Maksimova E.V., Klyaritskaia I.L. Hepatic encephalopathy, diagnostics, differential diagnostics and therapy with ornithine. Consilium Medicum. 2018; 20(12): 110–116 (In Russ.)).


https://doi.org/10.26442/20751753.2018.12.000019. EDN: YUHJIL.


7. Кутлубаев М.А. Выявление когнитивного дефицита в практике терапевта: обзор скрининговых шкал. Терапевтический архив. 2014; 86(11): 135–138. (Kutlubaev M.A. Detection of cognitive deficit in a therapist’s practice: Review of screening scales. Terapevticheskiy arkhiv = Therapeutic Archive. 2014; 86(11): 135–138 (In Russ.)). EDN: TGSDML.


8. Лазебник Л.Б., Голованова Е.В., Алексеенко С.А. с соавт. Российский консенсус «Гипераммониемии у взрослых» (Версия 2021). Экспериментальная и клиническая гастроэнтерология. 2021; (3): 97–118. (Lazebnik L.B., Golovanova E.V., Alekseenko S.A. et al. Russian consensus “Hyperammonemia in adults” (Version 2021). Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2021; (3): 97–118 (In Russ.)).


https://doi.org/10.31146/1682-8658-ecg-187-3-97-118. EDN: IXZDGZ.


9. Weissenborn K., Ruckert N., Hecker H., Manns M.P. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol. 1998; 28(4): 646–53.


https://doi.org/10.1016/S0168-8278(98)80289-4. PMID: 9566834.


10. Szymkowicz S.M., May P.E., Weeks J.W. et al. Psychometric properties of the Montreal Cognitive Assessment (MoCA) in inpatient liver transplant candidates. Appl Neuropsychol Adult. 2024; 31(1): 19–26.


https://doi.org/10.1080/23279095.2021.1986510. PMID: 34622723.


11. Koziarska D., Wunsch E., Milkiewicz M. et al. Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: A prospective, quantified electroencephalography study. BMC Gastroenterol. 2013; 13: 107.


https://doi.org/10.1186/1471-230X-13-107. PMID: 23815160. PMCID: PMC3716589.


12. Corrias M., Turco M., Rui M.D. et al. Covert hepatic encephalopathy: Does the mini-mental state examination help? J Clin Exp Hepatol. 2014; 4(2): 89–93.


https://doi.org/10.1016/j.jceh.2013.12.005. PMID: 25755545. PMCID: PMC4116703.


13. Gundling F., Zelihic E., Seidl H. et al. How to diagnose hepatic encephalopathy in the emergency department. Ann Hepatol. 2013; 12(1): 108–14. PMID: 23293201.


14. Jalan R., Rose C.F. Heretical thoughts into hepatic encephalopathy. J of Hepatol. 2022; 77(2): 539–48.


https://doi.org/10.1016/j.jhep.2022.03.014. PMID: 35358618.


15. Маевская М.В. Печеночная энцефалопатия: вопросы, актуальные для клинической практики. Медицинский совет. 2021; (15): 104–108. (Maevskaya M.V. Hepatic encephalopathy: Issues relevant to clinical practice. Meditsinskiy sovet = Medical Council. 2021; (15): 104–108 (In Russ.)).


https://doi.org/10.21518/2079-701X-2021-15-104-108. EDN: LGJJOA.


About the Autors


Alsou M. Galieva, resident of the Department of hospital therapy, Kazan State Medical University of the Ministry of Healthcare of Russia. Address: 420012, Kazan, 49 Butlerova St.
E-mail: also101@gmail.com
ORCID: https://orcid.org/0000-0002-8026-6698
Dilyara D. Mukhametova, MD, PhD (Medicine), assistant at the Department of hospital therapy, Kazan State Medical University of the Ministry of Healthcare of Russia. Address: 420012, Kazan, 49 Butlerova St.
E-mail: muhdilyara@gmail.com
ORCID: https://orcid.org/0000-0003-2102-0142
Elena N. Belousova, MD, PhD (Medicine), assistant at the Department of hospital therapy, Kazan State Medical University of the Ministry of Healthcare of Russia. Address: 420012, Kazan, 49 Butlerova St.
E-mail: vanilla16@mail.ru
ORCID: https://orcid.org/0000-0001-9369-4993
Gulshat R. Khazieva, resident of the Department of hospital therapy, Kazan State Medical University of the Ministry of Healthcare of Russia. Address: 420012, Kazan, 49 Butlerova St.
E-mail: postgulshat@mail.ru
ORCID: https://orcid.org/0009-0007-1006-8649
Azalia D. Valitova, student of Kazan State Medical University of the Ministry of Healthcare of Russia. Address: 420012, Kazan, 49 Butlerova St.
Email: azali1903@gmail.com
ORCID: https://orcid.org/0000-0001-8980-5830
Polina I. Levanova, MD, gastroenterologist at the Department of gastroenterology, Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan. Address: 420064, Kazan, 138 Orenburgsky Tract.
E-mail: levanpi97@gmail.com
ORCID: https://orcid.org/0009-0007-9257-9206
Alfiya Kh. Odintsova, MD, PhD (Medicine), head of the Department of gastroenterology, Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan. Address: 420064, Kazan, 138 Orenburgsky Tract.
E-mail: odincovaa@yandex.ru
ORCID: https://orcid.org/0000-0002-7148-8862
Diana I. Abdulganieva, MD, PhD (Medicine), head of the Department of hospital therapy, Kazan State Medical University of the Ministry of Healthcare of Russia. Address: 420012, Kazan, 49 Butlerova St.
E-mail: diana_s@mail.ru
ORCID: https://orcid.org/0000-0001-7069-2725


Similar Articles


Бионика Медиа